• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科患者中 COVID-19 炎症标志物与维生素 D 的关系

COVID-19 Inflammatory Markers and Vitamin D Relationship in Pediatric Patients.

作者信息

Bagiu Iulia Cristina, Scurtu Ileana Luminita, Horhat Delia Ioana, Mot Ion Cristian, Horhat Razvan Mihai, Bagiu Radu Vasile, Capraru Ionut Dragos, Diaconu Mircea Mihai, Adam Ovidiu, Ciornei Bogdan, Vulcanescu Dan Dumitru, Juganaru Iulius, Bondar Andrei-Cristian, Horhat Florin George

机构信息

Emergency Hospital for Children "Louis Turcanu", 300011 Timisoara, Romania.

Department of Microbiology, Multidisciplinary Research Center on Antimicrobial Resistance, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.

出版信息

Life (Basel). 2022 Dec 28;13(1):91. doi: 10.3390/life13010091.

DOI:10.3390/life13010091
PMID:36676040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9864767/
Abstract

BACKGROUND

Biomarkers play an important role in COVID-19, and more research in this regard is needed, especially in the case of children. This study aimed to look for a link between the C reactive protein (CRP), lactate dehydrogenase (LDH), creatine kinase (CK), vitamin D and COVID-19 in pediatric patients.

METHODS

This is a retrospective cohort study, performed on children diagnosed positively with COVID-19 at a children's hospital in western Romania. Available CRP, LDH, CK vitamin D and clinical severity were recorded. For each biomarker, groups were formed by patients' age. Mean/median group differences were assessed using Student's test or Mann-Whitney and Kruskal-Wallis with Dunn's post hoc tests. Association was assessed using the chi test, while correlation was assessed using Spearman's rank correlation.

RESULTS

181 positive children were studied between 1 August 2021 and 1 February 2022. Average age was 8.76 years (SD = 3.93). There were 94 (51.93%) males and 87 (48.07%) females. The cases were: 62 asymptomatic (34.25%), 107 mild (59.12%), 9 moderate (4.97%), 3 severe (1.66%). Regarding CRP, a significant difference between older and younger patients was observed ( = 0.0034). Clinical severity was associated with CRP ( = 0.0281), LDH ( = 0.0410) and vitamin D ( = 0.0444). Regarding CK, no differences or associations proved significant. Correlation testing was conducted for CRP, LDH, vitamin D and clinical signs. With the exception of LDH-CRP and LDH-vitamin D, all relationships proved statistically significant.

CONCLUSIONS

CRP, LDH and vitamin D levels are important biomarkers for COVID-19-positive pediatric patients, while CK was mostly within normal ranges.

摘要

背景

生物标志物在新冠病毒疾病(COVID-19)中发挥着重要作用,在这方面需要更多研究,尤其是针对儿童的研究。本研究旨在探寻儿科患者中C反应蛋白(CRP)、乳酸脱氢酶(LDH)、肌酸激酶(CK)、维生素D与COVID-19之间的联系。

方法

这是一项回顾性队列研究,研究对象为罗马尼亚西部一家儿童医院确诊为COVID-19阳性的儿童。记录可用的CRP、LDH、CK、维生素D及临床严重程度。针对每种生物标志物,按患者年龄分组。使用学生t检验或曼-惠特尼检验以及带有邓恩事后检验的克鲁斯卡尔-沃利斯检验评估组间均值/中位数差异。使用卡方检验评估关联性,使用斯皮尔曼等级相关性评估相关性。

结果

在2021年8月1日至2022年2月1日期间研究了181名阳性儿童。平均年龄为8.76岁(标准差=3.93)。男性94名(51.93%),女性87名(48.07%)。病例情况为:62例无症状(34.25%),107例轻症(59.12%),9例中症(4.97%),3例重症(1.66%)。关于CRP,观察到年长与年幼患者之间存在显著差异(P=0.0034)。临床严重程度与CRP(P=0.0281)、LDH(P=0.0410)和维生素D(P=0.0444)相关。关于CK,未证明存在显著差异或关联性。对CRP、LDH、维生素D与临床体征进行了相关性检验。除LDH-CRP和LDH-维生素D外,所有关系均证明具有统计学意义。

结论

CRP、LDH和维生素D水平是COVID-19阳性儿科患者的重要生物标志物,而CK大多在正常范围内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/0a59b5698ebb/life-13-00091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/838081a70f29/life-13-00091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/d34acfc88170/life-13-00091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/e67a10d593b7/life-13-00091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/93e127d30987/life-13-00091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/0a59b5698ebb/life-13-00091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/838081a70f29/life-13-00091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/d34acfc88170/life-13-00091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/e67a10d593b7/life-13-00091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/93e127d30987/life-13-00091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29e5/9864767/0a59b5698ebb/life-13-00091-g005.jpg

相似文献

1
COVID-19 Inflammatory Markers and Vitamin D Relationship in Pediatric Patients.儿科患者中 COVID-19 炎症标志物与维生素 D 的关系
Life (Basel). 2022 Dec 28;13(1):91. doi: 10.3390/life13010091.
2
COVID-19 Biomarkers Comparison: Children, Adults and Elders.COVID-19 生物标志物比较:儿童、成人和老年人。
Medicina (Kaunas). 2023 May 3;59(5):877. doi: 10.3390/medicina59050877.
3
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
4
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
5
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.乳酸脱氢酶和 C 反应蛋白可预测 COVID-19 患者的呼吸衰竭。
Clin Chim Acta. 2020 Oct;509:135-138. doi: 10.1016/j.cca.2020.06.012. Epub 2020 Jun 9.
6
The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital.维生素 D 水平与儿科 COVID-19 患者临床严重程度和炎症标志物的关系:大流行医院的单中心经验。
Eur J Pediatr. 2021 Aug;180(8):2699-2705. doi: 10.1007/s00431-021-04030-1. Epub 2021 Mar 31.
7
Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19.炎症标志物与 COVID-19 疾病进展及严重程度的关联
Cureus. 2024 Feb 24;16(2):e54840. doi: 10.7759/cureus.54840. eCollection 2024 Feb.
8
Understanding the Impact of COVID-19 on Roma Vulnerable Communities in Western Romania: Insights and Predictive Factors from a Retrospective Study.了解 COVID-19 对罗马尼亚西部罗姆人弱势社区的影响:回顾性研究的见解和预测因素。
Viruses. 2024 Mar 12;16(3):435. doi: 10.3390/v16030435.
9
Retrospective Analysis of Inflammatory Markers and Patient Characteristics in Hospitalized Covid-19 Patients: An Early Experience in Louisiana.住院新冠肺炎患者炎症标志物与患者特征的回顾性分析:路易斯安那州的早期经验
Cureus. 2020 Sep 5;12(9):e10257. doi: 10.7759/cureus.10257.
10
Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial.两种顺势疗法复方草药汤剂(Nilavembu Kudineer 和 Kaba Sura Kudineer)联合标准西药治疗轻中度有症状 COVID-19 患者的疗效:一项双盲、安慰剂对照的临床试验。
Trials. 2021 Aug 28;22(1):570. doi: 10.1186/s13063-021-05478-0.

引用本文的文献

1
COVID-19 in Children and Vitamin D.儿童 COVID-19 与维生素 D
Int J Mol Sci. 2024 Nov 14;25(22):12205. doi: 10.3390/ijms252212205.
2
Role of Vitamin D and Vitamin D Polymorphisms in COVID-19 Risk and Severity in Children: A Systematic Review.维生素D及维生素D基因多态性在儿童新冠病毒病风险及严重程度中的作用:一项系统评价
Cureus. 2024 May 29;16(5):e61326. doi: 10.7759/cureus.61326. eCollection 2024 May.
3
Vitamin D Levels in COVID-19 and NonCOVID-19 Pediatric Patients and Its Relationship with Clinical and Laboratory Characteristics.

本文引用的文献

1
Drugs for COVID-19: An Update.抗新冠病毒药物进展
Molecules. 2022 Dec 5;27(23):8562. doi: 10.3390/molecules27238562.
2
An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions.常见和高死亡率疾病的维生素 D 循证评价
J Am Board Fam Med. 2022 Dec 23;35(6):1217-1229. doi: 10.3122/jabfm.2022.220115R1. Epub 2022 Nov 17.
3
Vitamin D status can affect COVID-19 outcomes also in pediatric population.维生素D状态也会影响儿童人群的新冠疫情结局。
新冠病毒感染和非新冠病毒感染儿科患者的维生素D水平及其与临床和实验室特征的关系
Biomedicines. 2024 Apr 18;12(4):905. doi: 10.3390/biomedicines12040905.
4
Understanding the Impact of COVID-19 on Roma Vulnerable Communities in Western Romania: Insights and Predictive Factors from a Retrospective Study.了解 COVID-19 对罗马尼亚西部罗姆人弱势社区的影响:回顾性研究的见解和预测因素。
Viruses. 2024 Mar 12;16(3):435. doi: 10.3390/v16030435.
5
The bounds of meta-analytics and an alternative method.元分析的界限和一种替代方法。
Epidemiol Health. 2024;46:e2024016. doi: 10.4178/epih.e2024016. Epub 2024 Jan 7.
6
COVID-19 and Laboratory Markers from Romanian Patients-A Narrative Review.罗马尼亚患者的新冠病毒病与实验室指标——一项叙述性综述
Life (Basel). 2023 Aug 30;13(9):1837. doi: 10.3390/life13091837.
7
COVID-19 Biomarkers Comparison: Children, Adults and Elders.COVID-19 生物标志物比较:儿童、成人和老年人。
Medicina (Kaunas). 2023 May 3;59(5):877. doi: 10.3390/medicina59050877.
PharmaNutrition. 2022 Dec;22:100319. doi: 10.1016/j.phanu.2022.100319. Epub 2022 Oct 14.
4
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in children: update and new insights from the second report of an Iranian referral hospital.儿童感染严重急性呼吸综合征冠状病毒 2 相关多系统炎症综合征:伊朗转诊医院第二次报告的最新信息和新见解。
Epidemiol Infect. 2022 Oct 18;150:e179. doi: 10.1017/S0950268822001522.
5
Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study.儿童中新型冠状病毒奥密克戎亚型BA.2的维生素D水平与临床结局:一项纵向队列研究。
Front Nutr. 2022 Jul 25;9:960859. doi: 10.3389/fnut.2022.960859. eCollection 2022.
6
Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial.维生素D补充剂对住院COVID-19儿科患者的疗效和安全性:一项随机对照试验。
Front Pediatr. 2022 Jul 25;10:943529. doi: 10.3389/fped.2022.943529. eCollection 2022.
7
COVID-19 Infection Segmentation and Severity Assessment Using a Self-Supervised Learning Approach.使用自监督学习方法进行COVID-19感染分割与严重程度评估
Diagnostics (Basel). 2022 Jul 26;12(8):1805. doi: 10.3390/diagnostics12081805.
8
Prevalence of Vitamin D Deficiency in Children with Fractures: Before and during the COVID-19 Outbreak.儿童骨折患者维生素 D 缺乏症的患病率:在 COVID-19 疫情爆发前后。
Int J Clin Pract. 2022 Jun 22;2022:4410032. doi: 10.1155/2022/4410032. eCollection 2022.
9
Vitamin D: A Role Also in Long COVID-19?维生素 D:在长新冠中也有作用?
Nutrients. 2022 Apr 13;14(8):1625. doi: 10.3390/nu14081625.
10
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies.一目了然的 COVID-19:变种、药物设计和疗法的最新概述。
Viruses. 2022 Mar 10;14(3):573. doi: 10.3390/v14030573.